Literature DB >> 1866463

Radiation therapy in extrahepatic bile duct carcinoma.

M Mahe1, P Romestaing, B Talon, J M Ardiet, N Salerno, I Sentenac, J P Gerard.   

Abstract

Fifty-one patients with carcinoma of the extrahepatic bile ducts (EHBD) received radiation therapy between January 1980 and December 1988. The location of the tumors was: proximal third, 20 patients; middle third, 23 patients; distal third, 3; diffuse, 5 patients. Thirty-six patients underwent surgery with complete gross resection in 14 (10/14 with positive margins), incomplete gross resection in 12 and only biopsy in 10. Fifteen patients had only biliary drainage without laparotomy after cytologic diagnosis of malignancy in 11/15. Radiation therapy was done with curative intent after complete or incomplete resection (n = 26) and it was palliative in patients who had no resection or only biliary drainage (n = 25). Twenty-five patients received external radiation-therapy (ERT) alone to the tumor and lymph nodes (mean dose 45 Gy/2 Gy per fraction for cure, 35 Gy/10 fractions for palliation), 8 patients had only iridium-192 (192Ir) implant (50-60 Gy at a 1 cm radius for cure, 30 Gy for palliation), 17 patients had both ERT + 192Ir (ERT 42.5 Gy + 192Ir 10-15 Gy for cure; ERT 20 Gy/5 fractions + 192Ir 20-30 Gy for palliation) and one intra-operative irradiation + ERT. The overall survival for the entire group was 55, 28.5 and 15% at 12, 24, 36 months and median survival 12 months. Median survival was 22 months in patients treated with curative intent and only 10 months after palliative treatment (p 0.03). Among patients who had curative treatment, median survival was 27.5 months after complete gross resection and 13 months after incomplete gross resection (p 0.045).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1866463     DOI: 10.1016/0167-8140(91)90084-t

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.

Authors:  Hiroshi Itoh; Koji Nishijima; Yoshiyuki Kurosaka; Shigeru Takegawa; Masato Kiriyama; Shotaro Dohba; Yasuhiko Kojima; Yasuo Saitoh
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

2.  Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayasidani; Takeshi Sudo; Yasushi Hashimoto; Hiroki Ohge; Taijiro Sueda
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

3.  Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.

Authors:  H A Pitt; A Nakeeb; R A Abrams; J Coleman; S Piantadosi; C J Yeo; K D Lillemore; J L Cameron
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

Review 4.  Chemotherapy for the biliary tract cancers: moving toward improved survival time.

Authors:  Adriana Romiti; Chiara D'Antonio; Angelo Zullo; Ida Sarcina; Roberta Di Rocco; Viola Barucca; Valeria Durante; Paolo Marchetti
Journal:  J Gastrointest Cancer       Date:  2012-09

5.  Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer.

Authors:  Janusz Skowronek; Aleksander Sowier; Paweł Skrzywanek
Journal:  J Contemp Brachytherapy       Date:  2009-07-17

Review 6.  Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review.

Authors:  Divya Khosla; Samreen Zaheer; Rahul Gupta; Renu Madan; Shikha Goyal; Narendra Kumar; Rakesh Kapoor
Journal:  World J Gastrointest Endosc       Date:  2022-03-16

7.  Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.

Authors:  Kyu-Hyoung Lim; Do-Youn Oh; Eui Kyu Chie; Jin-Young Jang; Seock-Ah Im; Tae-You Kim; Sun-Whe Kim; Sung Whan Ha; Yung-Jue Bang
Journal:  BMC Cancer       Date:  2009-09-27       Impact factor: 4.430

8.  Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.

Authors:  Eunmi Gil; Jae-Won Joh; Hee Chul Park; Jeong Il Yu; Sang Hoon Jung; Jong Man Kim
Journal:  World J Surg Oncol       Date:  2015-07-29       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.